Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Mobile Health Units × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 31 Cisplatin 28 Carboplatin 15 Radiotherapy 14 Paclitaxel 14 Bevacizumab 14 Brachytherapy 13 Colposcopy 11 Specimen Handling 10 Nivolumab 10 Blood Specimen Collection 10 Gemcitabine 9 Radiation 8 Magnetic Resonance Spectroscopy 8 Human Papillomavirus DNA Tests 8 Drug Therapy 8 lenvatinib 6 atezolizumab 6 Platinum 6 dostarlimab 5 Radiotherapy, Intensity-Modulated 5 Methods 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 zimberelimab 4 toripalimab 4 spartalizumab 4 Topotecan 4 Restraint, Physical 4 Pemetrexed 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07181278 2025-12-02

OptiTri_MT

Institut de Recherche pour le Developpement

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡